| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Plaque, Atherosclerotic | 12 | 2023 | 153 | 1.410 |
Why?
|
| Myocardium | 6 | 2012 | 907 | 0.850 |
Why?
|
| Coronary Vessels | 13 | 2023 | 549 | 0.650 |
Why?
|
| Coronary Artery Disease | 9 | 2023 | 893 | 0.610 |
Why?
|
| Liposomes | 6 | 2022 | 203 | 0.580 |
Why?
|
| Regeneration | 3 | 2010 | 225 | 0.570 |
Why?
|
| Tissue Plasminogen Activator | 4 | 2024 | 121 | 0.550 |
Why?
|
| Contrast Media | 5 | 2025 | 507 | 0.540 |
Why?
|
| Myocardial Infarction | 7 | 2021 | 1062 | 0.510 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 4 | 2013 | 87 | 0.490 |
Why?
|
| Myocytes, Cardiac | 6 | 2021 | 652 | 0.450 |
Why?
|
| Tomography, Optical Coherence | 6 | 2023 | 490 | 0.440 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2015 | 381 | 0.440 |
Why?
|
| Arteries | 3 | 2022 | 222 | 0.430 |
Why?
|
| Heart | 2 | 2015 | 689 | 0.400 |
Why?
|
| Nanoparticles | 3 | 2025 | 288 | 0.400 |
Why?
|
| Disease Models, Animal | 16 | 2025 | 4687 | 0.380 |
Why?
|
| Stem Cell Transplantation | 2 | 2010 | 249 | 0.370 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2025 | 2166 | 0.340 |
Why?
|
| Myocardial Ischemia | 3 | 2011 | 341 | 0.340 |
Why?
|
| Aortography | 3 | 2021 | 183 | 0.340 |
Why?
|
| Macrophages | 5 | 2019 | 692 | 0.340 |
Why?
|
| Aorta | 5 | 2025 | 552 | 0.330 |
Why?
|
| Aortic Aneurysm | 2 | 2025 | 237 | 0.320 |
Why?
|
| Adult Stem Cells | 1 | 2010 | 54 | 0.320 |
Why?
|
| Cardiology | 1 | 2015 | 497 | 0.320 |
Why?
|
| Animals | 33 | 2025 | 34845 | 0.300 |
Why?
|
| Fibrinolytic Agents | 3 | 2024 | 207 | 0.290 |
Why?
|
| Swine | 11 | 2024 | 1179 | 0.290 |
Why?
|
| Triiodobenzoic Acids | 2 | 2021 | 31 | 0.270 |
Why?
|
| Cell Death | 1 | 2008 | 243 | 0.270 |
Why?
|
| Regenerative Medicine | 1 | 2007 | 35 | 0.270 |
Why?
|
| Thrombosis | 3 | 2022 | 528 | 0.260 |
Why?
|
| Nitric Oxide | 3 | 2015 | 470 | 0.260 |
Why?
|
| Atherosclerosis | 3 | 2013 | 1006 | 0.250 |
Why?
|
| Cicatrix | 1 | 2007 | 121 | 0.250 |
Why?
|
| Heart Failure | 4 | 2011 | 2398 | 0.230 |
Why?
|
| Heart Diseases | 1 | 2010 | 511 | 0.230 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2021 | 375 | 0.230 |
Why?
|
| X-Ray Microtomography | 2 | 2023 | 95 | 0.220 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2015 | 36 | 0.210 |
Why?
|
| Thrombolytic Therapy | 3 | 2024 | 216 | 0.210 |
Why?
|
| Molecular Imaging | 2 | 2015 | 63 | 0.210 |
Why?
|
| Fractures, Stress | 1 | 2023 | 14 | 0.210 |
Why?
|
| Adipose Tissue | 1 | 2007 | 510 | 0.210 |
Why?
|
| Lithotripsy, Laser | 1 | 2023 | 19 | 0.210 |
Why?
|
| Wound Healing | 1 | 2007 | 475 | 0.200 |
Why?
|
| Glucose | 3 | 2021 | 871 | 0.200 |
Why?
|
| Aorta, Abdominal | 2 | 2015 | 118 | 0.200 |
Why?
|
| Vascular Calcification | 1 | 2023 | 71 | 0.200 |
Why?
|
| Venous Thrombosis | 1 | 2024 | 170 | 0.190 |
Why?
|
| Ultrasonic Therapy | 2 | 2013 | 28 | 0.190 |
Why?
|
| Optical Imaging | 2 | 2020 | 73 | 0.190 |
Why?
|
| Predictive Value of Tests | 7 | 2023 | 2314 | 0.180 |
Why?
|
| Prosthesis-Related Infections | 2 | 2015 | 187 | 0.180 |
Why?
|
| Anti-Infective Agents | 2 | 2015 | 270 | 0.180 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 2442 | 0.180 |
Why?
|
| Cardiomegaly | 1 | 2021 | 124 | 0.170 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2021 | 167 | 0.170 |
Why?
|
| Inflammation | 2 | 2009 | 1522 | 0.160 |
Why?
|
| Coronary Angiography | 3 | 2007 | 487 | 0.160 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 398 | 0.160 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2015 | 515 | 0.160 |
Why?
|
| In Vitro Techniques | 6 | 2024 | 861 | 0.160 |
Why?
|
| Aortic Rupture | 1 | 2021 | 119 | 0.160 |
Why?
|
| Computed Tomography Angiography | 1 | 2021 | 215 | 0.150 |
Why?
|
| Staphylococcal Infections | 2 | 2015 | 569 | 0.150 |
Why?
|
| Stress, Physiological | 2 | 2012 | 260 | 0.150 |
Why?
|
| Ultrasonography | 8 | 2022 | 988 | 0.150 |
Why?
|
| Heart-Assist Devices | 3 | 2013 | 1085 | 0.140 |
Why?
|
| Endothelium, Vascular | 2 | 2014 | 486 | 0.130 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2014 | 122 | 0.130 |
Why?
|
| Polyethylene Terephthalates | 2 | 2015 | 30 | 0.130 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2015 | 787 | 0.120 |
Why?
|
| Cell Movement | 1 | 2019 | 890 | 0.120 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2021 | 425 | 0.120 |
Why?
|
| Luminescent Measurements | 1 | 2015 | 60 | 0.120 |
Why?
|
| Transplantation, Heterologous | 2 | 2013 | 272 | 0.120 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 66 | 0.110 |
Why?
|
| Injections | 1 | 2015 | 152 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 2087 | 0.110 |
Why?
|
| Swine, Miniature | 4 | 2015 | 52 | 0.110 |
Why?
|
| Humans | 24 | 2023 | 132238 | 0.110 |
Why?
|
| Stem Cells | 2 | 2010 | 732 | 0.110 |
Why?
|
| Cardiovascular Agents | 1 | 2015 | 87 | 0.110 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 109 | 0.110 |
Why?
|
| Ultrasonics | 2 | 2013 | 36 | 0.110 |
Why?
|
| Cadaver | 3 | 2019 | 119 | 0.110 |
Why?
|
| Recombinant Proteins | 2 | 2022 | 1350 | 0.110 |
Why?
|
| Endocardium | 2 | 2011 | 54 | 0.100 |
Why?
|
| Transplantation, Homologous | 3 | 2010 | 650 | 0.100 |
Why?
|
| Time Factors | 7 | 2021 | 6451 | 0.100 |
Why?
|
| Dogs | 3 | 2008 | 651 | 0.100 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2013 | 47 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 5 | 2025 | 4758 | 0.100 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2019 | 231 | 0.100 |
Why?
|
| Pluripotent Stem Cells | 1 | 2013 | 75 | 0.090 |
Why?
|
| Endovascular Procedures | 1 | 2021 | 785 | 0.090 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2013 | 66 | 0.090 |
Why?
|
| Blood Coagulation | 1 | 2013 | 129 | 0.090 |
Why?
|
| Cell Differentiation | 3 | 2008 | 1963 | 0.090 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2011 | 37 | 0.090 |
Why?
|
| Body Temperature | 1 | 2011 | 128 | 0.090 |
Why?
|
| X-Ray Intensifying Screens | 1 | 2010 | 3 | 0.090 |
Why?
|
| Fluorocarbons | 1 | 2011 | 58 | 0.090 |
Why?
|
| Carotid Arteries | 1 | 2011 | 135 | 0.080 |
Why?
|
| Male | 16 | 2025 | 65013 | 0.080 |
Why?
|
| Aortic Diseases | 1 | 2013 | 197 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2021 | 4718 | 0.080 |
Why?
|
| Mice | 7 | 2025 | 18502 | 0.080 |
Why?
|
| Connective Tissue | 2 | 2007 | 28 | 0.080 |
Why?
|
| Immunity, Cellular | 1 | 2010 | 203 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2011 | 463 | 0.080 |
Why?
|
| Calcinosis | 2 | 2007 | 191 | 0.080 |
Why?
|
| Orthomyxoviridae | 1 | 2009 | 52 | 0.080 |
Why?
|
| Cardiomyopathies | 2 | 2011 | 509 | 0.080 |
Why?
|
| Circadian Rhythm | 1 | 2011 | 316 | 0.080 |
Why?
|
| Ventricular Function, Left | 1 | 2013 | 548 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2010 | 258 | 0.070 |
Why?
|
| Histological Techniques | 1 | 2008 | 21 | 0.070 |
Why?
|
| Clinical Trials as Topic | 2 | 2010 | 1161 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 224 | 0.070 |
Why?
|
| Fibronectins | 1 | 2008 | 103 | 0.070 |
Why?
|
| Laminin | 1 | 2008 | 72 | 0.070 |
Why?
|
| Ultrasonography, Interventional | 2 | 2020 | 208 | 0.070 |
Why?
|
| Fibrinogen | 1 | 2008 | 157 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2008 | 237 | 0.070 |
Why?
|
| Collagen | 1 | 2008 | 303 | 0.070 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2007 | 238 | 0.070 |
Why?
|
| Ferric Compounds | 1 | 2007 | 40 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2012 | 698 | 0.060 |
Why?
|
| Prosthesis Design | 3 | 2015 | 670 | 0.060 |
Why?
|
| Genetic Therapy | 1 | 2011 | 720 | 0.060 |
Why?
|
| Apoptosis | 2 | 2010 | 1899 | 0.060 |
Why?
|
| Autophagy | 1 | 2009 | 426 | 0.060 |
Why?
|
| Research Design | 2 | 2007 | 743 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2024 | 1294 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2007 | 605 | 0.060 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 2 | 2019 | 37 | 0.060 |
Why?
|
| Particle Size | 1 | 2025 | 149 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2011 | 916 | 0.060 |
Why?
|
| High-Intensity Focused Ultrasound Ablation | 1 | 2024 | 4 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 3018 | 0.050 |
Why?
|
| Iron | 1 | 2007 | 302 | 0.050 |
Why?
|
| Minocycline | 2 | 2015 | 42 | 0.050 |
Why?
|
| Chlorhexidine | 2 | 2015 | 47 | 0.050 |
Why?
|
| Respiratory Tract Infections | 1 | 2007 | 291 | 0.050 |
Why?
|
| Permeability | 2 | 2014 | 117 | 0.050 |
Why?
|
| Algorithms | 3 | 2020 | 1725 | 0.050 |
Why?
|
| Biomarkers | 3 | 2020 | 3404 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2005 | 189 | 0.050 |
Why?
|
| Rifampin | 2 | 2015 | 120 | 0.050 |
Why?
|
| Scattering, Radiation | 2 | 2016 | 56 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2021 | 1444 | 0.050 |
Why?
|
| Antigens, CD | 2 | 2019 | 436 | 0.050 |
Why?
|
| Urinary Tract Infections | 1 | 2007 | 317 | 0.050 |
Why?
|
| Random Allocation | 2 | 2013 | 431 | 0.050 |
Why?
|
| Elasticity | 1 | 2022 | 78 | 0.050 |
Why?
|
| Sepsis | 1 | 2007 | 516 | 0.050 |
Why?
|
| Thrombin | 1 | 2022 | 59 | 0.050 |
Why?
|
| Sus scrofa | 2 | 2013 | 121 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2021 | 3045 | 0.050 |
Why?
|
| Rabbits | 2 | 2014 | 673 | 0.040 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2021 | 18 | 0.040 |
Why?
|
| Isomerases | 1 | 2021 | 22 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2005 | 526 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2024 | 13027 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 2 | 2013 | 327 | 0.040 |
Why?
|
| Cattle | 1 | 2022 | 569 | 0.040 |
Why?
|
| Dilatation, Pathologic | 1 | 2021 | 89 | 0.040 |
Why?
|
| Apolipoproteins E | 2 | 2013 | 201 | 0.040 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2021 | 65 | 0.040 |
Why?
|
| Hyperlipidemias | 2 | 2013 | 188 | 0.040 |
Why?
|
| Myocardial Contraction | 2 | 2012 | 254 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 436 | 0.040 |
Why?
|
| Angiotensin II | 1 | 2021 | 163 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2021 | 198 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2021 | 618 | 0.040 |
Why?
|
| Fibrosis | 2 | 2016 | 421 | 0.040 |
Why?
|
| Female | 9 | 2021 | 70780 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2007 | 2510 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2013 | 821 | 0.040 |
Why?
|
| Rupture, Spontaneous | 1 | 2019 | 47 | 0.040 |
Why?
|
| Automation | 1 | 2019 | 63 | 0.040 |
Why?
|
| Equipment Design | 2 | 2013 | 600 | 0.040 |
Why?
|
| Sirolimus | 1 | 2021 | 241 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2021 | 255 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2012 | 679 | 0.040 |
Why?
|
| Calcium | 1 | 2023 | 1080 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2021 | 1612 | 0.030 |
Why?
|
| Stents | 1 | 2022 | 874 | 0.030 |
Why?
|
| Light | 1 | 2016 | 183 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 2451 | 0.030 |
Why?
|
| Coronary Stenosis | 2 | 2007 | 83 | 0.030 |
Why?
|
| Echocardiography | 1 | 2021 | 1126 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 1234 | 0.030 |
Why?
|
| Middle Aged | 5 | 2016 | 29021 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 2232 | 0.030 |
Why?
|
| Microbubbles | 1 | 2014 | 10 | 0.030 |
Why?
|
| Diet | 1 | 2021 | 1125 | 0.030 |
Why?
|
| Acoustics | 1 | 2013 | 21 | 0.030 |
Why?
|
| Aged | 4 | 2016 | 21482 | 0.030 |
Why?
|
| Antigens, Heterophile | 1 | 2013 | 2 | 0.030 |
Why?
|
| Antibodies, Heterophile | 1 | 2013 | 10 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2013 | 3868 | 0.030 |
Why?
|
| High-Energy Shock Waves | 1 | 2013 | 7 | 0.030 |
Why?
|
| Heart Function Tests | 1 | 2013 | 55 | 0.030 |
Why?
|
| Magnetics | 1 | 2013 | 37 | 0.020 |
Why?
|
| Uncoupling Protein 3 | 1 | 2012 | 7 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 2139 | 0.020 |
Why?
|
| Biopsy | 1 | 2016 | 1288 | 0.020 |
Why?
|
| Oleic Acid | 1 | 2012 | 18 | 0.020 |
Why?
|
| Risk Factors | 1 | 2007 | 10944 | 0.020 |
Why?
|
| Sheep | 1 | 2013 | 229 | 0.020 |
Why?
|
| Dietary Sucrose | 1 | 2012 | 41 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2013 | 364 | 0.020 |
Why?
|
| Systole | 1 | 2011 | 205 | 0.020 |
Why?
|
| Cricetinae | 1 | 2011 | 381 | 0.020 |
Why?
|
| Perfusion | 1 | 2012 | 208 | 0.020 |
Why?
|
| Extracorporeal Circulation | 1 | 2011 | 55 | 0.020 |
Why?
|
| Ion Channels | 1 | 2012 | 206 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2012 | 260 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 802 | 0.020 |
Why?
|
| Rhodamines | 1 | 2010 | 22 | 0.020 |
Why?
|
| Lipid Bilayers | 1 | 2010 | 49 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2010 | 82 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 138 | 0.020 |
Why?
|
| Linear Models | 1 | 2011 | 714 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 541 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1008 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 1224 | 0.020 |
Why?
|
| Necrosis | 1 | 2009 | 210 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2009 | 140 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 673 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 1177 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2013 | 861 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2009 | 251 | 0.020 |
Why?
|
| Models, Animal | 1 | 2010 | 469 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2007 | 45 | 0.020 |
Why?
|
| Cell Line | 1 | 2013 | 2724 | 0.020 |
Why?
|
| Surface Properties | 1 | 2007 | 93 | 0.020 |
Why?
|
| Mitochondria | 1 | 2013 | 751 | 0.020 |
Why?
|
| Insulin | 1 | 2012 | 1168 | 0.020 |
Why?
|
| Tunica Media | 1 | 2007 | 15 | 0.020 |
Why?
|
| S100 Proteins | 1 | 2007 | 47 | 0.020 |
Why?
|
| Coronary Thrombosis | 1 | 2007 | 35 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2007 | 55 | 0.020 |
Why?
|
| CD3 Complex | 1 | 2007 | 92 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2011 | 1233 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 3604 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2009 | 613 | 0.010 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2005 | 20 | 0.010 |
Why?
|
| Injections, Intralesional | 1 | 2005 | 47 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 2005 | 64 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 1883 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2005 | 249 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2005 | 222 | 0.010 |
Why?
|
| Lipids | 1 | 2007 | 561 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2005 | 412 | 0.010 |
Why?
|
| Syndrome | 1 | 2007 | 1175 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2007 | 448 | 0.010 |
Why?
|
| Troponin I | 1 | 2005 | 125 | 0.010 |
Why?
|
| Acute Disease | 1 | 2007 | 1163 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2005 | 210 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2005 | 358 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2005 | 536 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 5176 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2005 | 464 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 3736 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2009 | 1597 | 0.010 |
Why?
|
| Adult | 2 | 2011 | 31614 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2007 | 3414 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 3092 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 5410 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2007 | 1757 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 7138 | 0.010 |
Why?
|
| Phenotype | 1 | 2005 | 4540 | 0.010 |
Why?
|